Literature DB >> 17754936

Trypanosoma cruzi Endotoxin (KR) in the Treatment of Malignant Mouse Tumors.

T S Hauschka, M B Goodwin.   

Abstract

Entities:  

Keywords:  TRYPANOSOMA/toxin; TUMORS/experimental; TUMORS/therapy

Mesh：

Substances：

Year:  1948        PMID： 17754936     DOI： 10.1126/science.107.2788.600

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  10 in total

1.  Chemical agents in neoplastic diseases; an evaluation of chemotherapeutic substances for clinical management.

Authors:  H R BIERMAN
Journal:  Calif Med       Date:  1953-01

2.  Trypanosoma cruzi as an effective cancer antigen delivery vector.

Authors:  Caroline Junqueira; Luara I Santos; Bruno Galvão-Filho; Santuza M Teixeira; Flávia G Rodrigues; Wanderson D DaRocha; Egler Chiari; Achim A Jungbluth; Gerd Ritter; Sacha Gnjatic; Lloyd J Old; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-23       Impact factor: 11.205

3.  The causation and importance of nervous lesions in American trypanosomiasis.

Authors:  F Köberle
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  [Tumor therapy with parasites and microorganisms].

Authors:  D Gericke
Journal:  Naturwissenschaften       Date:  1965-12

5.  Antiangiogenic and antitumor effects of Trypanosoma cruzi Calreticulin.

Authors:  Nandy C López; Carolina Valck; Galia Ramírez; Margarita Rodríguez; Carolina Ribeiro; Juana Orellana; Ismael Maldonado; Adriana Albini; Daniel Anacona; David Lemus; Lorena Aguilar; Wilhelm Schwaeble; Arturo Ferreira
Journal:  PLoS Negl Trop Dis       Date:  2010-07-06

Review 6.  Is it all That Bad When Living with an Intracellular Protozoan? The Role of Trypanosoma cruzi Calreticulin in Angiogenesis and Tumor Growth.

Authors:  Galia Ramírez-Toloza; Lorena Aguilar-Guzmán; Carolina Valck; Paula Abello; Arturo Ferreira
Journal:  Front Oncol       Date:  2015-01-13       Impact factor: 6.244

Review 7.  Trypanosoma cruzi Evades the Complement System as an Efficient Strategy to Survive in the Mammalian Host: The Specific Roles of Host/Parasite Molecules and Trypanosoma cruzi Calreticulin.

Authors:  Galia Ramírez-Toloza; Arturo Ferreira
Journal:  Front Microbiol       Date:  2017-09-01       Impact factor: 5.640

Review 8.  Is It Possible to Intervene in the Capacity of Trypanosoma cruzi to Elicit and Evade the Complement System?

Authors:  Galia Ramírez-Toloza; Lorena Aguilar-Guzmán; Carolina Valck; Smrithi S Menon; Viviana P Ferreira; Arturo Ferreira
Journal:  Front Immunol       Date:  2021-12-16       Impact factor: 7.561

Review 9.  Anti-Tumor Effect of Parasitic Protozoans.

Authors:  Haojie Ding; Songrui Wu; Zi Jin; Bin Zheng; Yuan Hu; Ke He; Shaohong Lu; Xunhui Zhuo
Journal:  Bioengineering (Basel)       Date:  2022-08-16

Review 10.  Is the Antitumor Property of Trypanosoma cruzi Infection Mediated by Its Calreticulin?

Authors:  Galia Ramírez-Toloza; Paula Abello; Arturo Ferreira
Journal:  Front Immunol       Date:  2016-07-11       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.